retatrutide clinical trials results weight loss Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Early trial data for retatrutide

Constipation is managed with adequate fiber, hydration, and if needed, gentle fiber supplements

Barakat, G

Long-chain omega 3 fatty acids: molecular bases of potential antioxidant actions

Dual- and triple action approaches which simultaneously target multiple pathways, for example, GLP1R/GIP (tirzepatide), GLP1R/GIP/glucagon (retatrutide) or amylin/GLP1R (CagriSemra) appear more potent and may push weight reduction to the mid-20% range and possibly beyond, while oral options seek to deliver levels of efficacy seen with injectables

Notably, senescent renal TECs may induce fibroblast activation and proliferation by releasing Sonic hedgehog protein, contributing to the progression of DKD (13)

Been taking Insulin or Sulfonylureas, because they can raise the risk of Hypoglycemia (low blood sugar)